A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines

References

• Vader G, Lens SM. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 2008;1786:60–72.
   PubMed Web of Science ®Google Scholar
• Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003;4:842–854.
   PubMed Web of Science ®Google Scholar
• Liu Q, Kaneko S, Yang L, . Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem 2004;279:52175–52182.
   PubMed Web of Science ®Google Scholar
• Ouchi M, Fujiuchi N, Sasai K, . BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition. J Biol Chem 2004;279:19643–19648.
   PubMed Web of Science ®Google Scholar
• Yang H, Ou CC, Feldman RI, . Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res 2004;64:463–467.
   PubMed Web of Science ®Google Scholar
• Ulisse S, Baldini E, Toller M, . Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocr Relat Cancer 2007;14: 827–837.
   PubMed Web of Science ®Google Scholar
• Briassouli P, Chan F, Savage K, . Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha. Cancer Res 2007;67:1689–1695.
   PubMed Web of Science ®Google Scholar
• Bayliss R, Sardon T, Vernos I, . Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol Cell 2003;12:851–862.
   PubMed Web of Science ®Google Scholar
• Kufer TA, Sillje HH, Korner R, . Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002;158:617–623.
   PubMed Web of Science ®Google Scholar
• Wittmann T, Wilm M, Karsenti E, . TPX2, a novel xenopus MAP involved in spindle pole organization. J Cell Biol 2000;149:1405–1418.
   PubMed Web of Science ®Google Scholar
• Hirota T, Kunitoku N, Sasayama T, . Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 2003;114:585–598.
   PubMed Web of Science ®Google Scholar
• Pugacheva EN, Jablonski SA, Hartman TR, . HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 2007;129:1351–1363.
   PubMed Web of Science ®Google Scholar
• Molli PR, Li DQ, Bagheri-Yarmand R, . Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. J Cell Biol 2010;190:101–114.
   PubMed Web of Science ®Google Scholar
• Dar AA, Goff LW, Majid S, . Aurora kinase inhibitors—rising stars in cancer therapeutics? Mol Cancer Ther 2010;9:268–278.
   PubMed Web of Science ®Google Scholar
• Nicolaides C, Dimou S, Pavlidisa N. Prognostic factors in aggressive non-Hodgkin's Lymphomas. Oncologist 1998;3:189–197.
   PubMedGoogle Scholar
• Gautschi O, Mack PC, Davies AM, . Aurora kinase inhibitors: a new class of targeted drugs in cancer. Clin Lung Cancer 2006;8:93–98.
   PubMed Web of Science ®Google Scholar
• Hata T, Furukawa T, Sunamura M, . RNA interference targeting Aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005;65:2899–2905.
   PubMed Web of Science ®Google Scholar
• Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004;4:927–936.
   PubMed Web of Science ®Google Scholar
• Yakushijin Y, Hamada M, Yasukawa M. The expression of the Aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma. Leuk Lymphoma 2004;45:1741–1746.
   PubMed Web of Science ®Google Scholar
• Cheung CH, Coumar MS, Hsieh HP, . Aurora kinase inhibitors in preclinical and clinical testing. Expert Opin Investig Drugs 2009;18: 379–398.
   PubMed Web of Science ®Google Scholar
• Tsai MY, Wiese C, Cao K, . A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat Cell Biol 2003;5:242–248.
   PubMed Web of Science ®Google Scholar
• Telford WG, King LE, Fraker PJ. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 1991;24:447–459.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Weisenburger DD, Chowdhury A, . Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia 2011;25:1377.
   Web of Science ®Google Scholar
• Shimomura T, Hasako S, Nakatsuru Y, . MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol Cancer Ther 2010;9:157–166.
   PubMed Web of Science ®Google Scholar
• Tyler RK, Shpiro N, Marquez R, . VX-680 inhibits Aurora A and Aurora B kinase activity in human cells. Cell Cycle 2007;6:2846–2854.
   PubMed Web of Science ®Google Scholar
• Carpinelli P, Ceruti R, Giorgini ML, . PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer. Mol Cancer Ther 2007;6:3158–3168.
   PubMed Web of Science ®Google Scholar
• Guo J, Anderson MG, Tapang P, . Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152. Pharmacogenomics J 2009;9:90–102.
   PubMed Web of Science ®Google Scholar
• Lin ZZ, Hsu HC, Hsu CH, . The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. J Hepatol 2009;50:518–527.
   PubMed Web of Science ®Google Scholar
• Hirota T, Lipp JJ, Toh BH, . Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 2005;438:1176–1180.
   PubMed Web of Science ®Google Scholar
• Bortner CD, Oldenburg NB, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol 1995;5:21–26.
   PubMed Web of Science ®Google Scholar
• Scott FL, Denault JB, Riedl SJ, . XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J 2005;24:645–655.
   PubMed Web of Science ®Google Scholar
• Mao JH, Wu D, Perez-Losada J, . Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice. Cancer Cell 2007;11:161–173.
   PubMed Web of Science ®Google Scholar
• Hill R, Bodzak E, Blough MD, . p53 Binding to the p21 promoter is dependent on the nature of DNA damage. Cell Cycle 2008;7:2535–2543.
   PubMed Web of Science ®Google Scholar
• Gillis LD, Leidal AM, Hill R, . p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle 2009;8: 253–256.
   PubMed Web of Science ®Google Scholar
• Dar AA, Belkhiri A, Ecsedy J, . Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells. Cancer Res 2008;68:8998–9004.
   PubMed Web of Science ®Google Scholar
• Allan LA, Clarke PR. Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 2007;26: 301–310.
   PubMed Web of Science ®Google Scholar
• Andersen JL, Johnson CE, Freel CD, . Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2. EMBO J 2009;28:3216–3227.
   PubMed Web of Science ®Google Scholar
• Qin L, Tong T, Song Y, . Aurora-A interacts with cyclin B1 and enhances its stability. Cancer Lett 2009;275:77–85.
   PubMed Web of Science ®Google Scholar
• Sardon T, Peset I, Petrova B, . Dissecting the role of Aurora A during spindle assembly. EMBO J 2008;27:2567–2579.
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Noetzel TL, Pelletier L, . Aurora A phosphorylation of TACC3/maskin is required for centrosome-dependent microtubule assembly in mitosis. J Cell Biol 2005;170:1047–1055.
   PubMed Web of Science ®Google Scholar
• Kim M, Gans JD, Nogueira C, . Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006;125: 1269–1281.
   PubMed Web of Science ®Google Scholar
• O'Neill GM, Seo S, Serebriiskii IG, . A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 2007;67: 8975–8979.
   Google Scholar
• Ozlu N, Srayko M, Kinoshita K, . An essential function of the C. elegans ortholog of TPX2 is to localize activated aurora A kinase to mitotic spindles. Dev Cell 2005;9:237–248.
   PubMed Web of Science ®Google Scholar
• Anderson K, Yang J, Koretke K, . Binding of TPX2 to Aurora A alters substrate and inhibitor interactions. Biochemistry 2007;46: 10287–10295.
   PubMed Web of Science ®Google Scholar